Prognostic analysis of liver transplantation in treating patients with end-stage autoimmune liver disease
10.3969/j.issn.1674-7445.2014.04.006
- VernacularTitle:肝移植治疗终末期自身免疫性肝病的预后分析
- Author:
You ZOU
1
;
Lei ZHANG
;
Ruidong LI
;
Wenyuan GUO
;
Guoshan DING
;
Zhiren FU
;
Zhengxin WANG
Author Information
1. 第二军医大学附属长征医院器官移植中心
- Keywords:
Liver transplantation;
Autoimmune liver disease;
Autoimmune hepatitis;
Primary biliary cirrhosis;
Primary sclerosing cholangitis;
Adrenocortical hormone
- From:
Organ Transplantation
2014;(4):222-226
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the prognosis of patients underwent liver transplantation (LT) for end-stage autoimmune liver disease (AILD). Methods Clinical data of 48 patients with end-stage AILD undergoing LT from May 1996 to April 2013 in Affiliated Changzheng Hospital of the Second Military Medical University were analyzed retrospectively. The postoperative cumulative survival rates of the recipients were calculated,and the cause of death was analyzed. The postoperative rejections,new-onset viral hepatitis and AILD recurrence were analyzed. Results In 48 AILD recipients,38 cases survived and the postoperative 5-year cumulative survival rate was 76%. Causes of death for the 10 dead cases were multiple organ failure, liver graft failure,sepsis,pulmonary infection,hemorrhage,hepatic artery embolization and renal failure. In 48 AILD recipients,9 cases (19%) suffered acute rejection after operation,3 cases suffered new-onset hepatitis B infection in 1-2 years after operation,2 recipients suffered primary disease (primary biliary cirrhosis)recurrence 2 years after operation and all survived for a long term after positive treatments.Conclusions Most liver transplant recipients with end-stage AILD can obtain a long-term survival. Attentions should be paid on the immunosuppressive regimens in early period after LT,prevention of infection,rejection and postoperative new-onset viral hepatitis,timely diagnosis of primary disease recurrence.
